Skip to main content
Fig. 2 | BMC Endocrine Disorders

Fig. 2

From: The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile

Fig. 2

Weights of epididymal (a), inguinal (b) and perirenal (c) white adipose tissue (AT) at study end (n = 8–10 rats per group). Statistical analysis between groups (a and b) were performed as a one-way ANONA followed by Tukey’s post-hoc test and as Kruskal Wallis test followed by Dunn’s post-hoc test with the following annotations: *P < 0.05, **P < 0.01, ***P < 0.001 vs. vehicle, §P < 0.05, §§P < 0.01 vs. liraglutide (400 μg/kg). All data are means ± SEM

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us